市场调查报告书

动物用医药品的全球市场:各类型产品 、各产品(外部寄生虫驱除剂,内部寄生虫驱除剂,抗发炎药,支气管扩张药),动物的各类型、各登记、各地区的预测和机会

Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品编码 934730
出版日期 内容资讯 英文 114 Pages
商品交期: 请询问到货日
价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

动物用医药品的全球市场:各类型产品 、各产品(外部寄生虫驱除剂,内部寄生虫驱除剂,抗发炎药,支气管扩张药),动物的各类型、各登记、各地区的预测和机会 Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日内容资讯: 英文 114 Pages
简介

动物用医药品的市场,大致区分为宠物用和产业动物用,前者的市场占著很大的占有率。北美地区是最大的市场,畜产繁盛,宠物的饲养数也多,亚太地区的市场也急速成长。各国政府的动物实验相关法规的强化,电子商务平台销售的假药等问题,虽然成为阻碍成长的要素于,但是市场预测到2025年继续踏实成长。

本报告提供全球动物用医药品市场调查,各地区市场展望,市场力学与趋势,竞争情形和主要企业的简介等资讯,同时再加上策略性建议。

目录

第1章 产品概要

第2章 调查方法

第3章 摘要整理

第4章 客户的回响

第5章 全球市场的展望

  • 市场规模与预测
    • 以金额为准和以数量为准
  • 市场占有率与预测
    • 各类型产品 (疫苗,兽医用医药品,其他)
    • 各产品
    • 动物的各类型(宠物,产业动物)
    • 各登记(学名药,专利药)
    • 各地区(亚太地区,欧洲、 北美,南美,中东、非洲)
    • 各企业(2019年)
  • 产品市场地图

第6章 亚太地区市场展望

  • 市场规模与预测
    • 以金额为准和以数量为准
  • 市场占有率与预测
    • 各类型产品
    • 各产品
    • 动物的各类型
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第7章 欧洲市场展望

  • 市场规模与预测
    • 以金额为准和以数量为准
  • 市场占有率与预测
    • 各类型产品
    • 各产品
    • 动物的各类型
    • 各国
  • 欧洲:各国分析
    • 英国
    • 义大利
    • 法国
    • 德国
    • 西班牙

第8章 北美市场展望

  • 市场规模与预测
    • 以金额为准和以数量为准
  • 市场占有率与预测
    • 各类型产品
    • 各产品
    • 动物的各类型
    • 各国
  • 北美:各国分析
    • 美国
    • 加拿大
    • 墨西哥

第9章 南美市场展望

  • 市场规模与预测
    • 以金额为准和以数量为准
  • 市场占有率与预测
    • 各类型产品
    • 各产品
    • 动物的各类型
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第10章 中东、非洲市场展望

  • 市场规模与预测
    • 以金额为准和以数量为准
  • 市场占有率与预测
    • 各类型产品
    • 各产品
    • 动物的各类型
    • 各国
  • 中东、非洲:各国分析
    • UAE
    • 沙乌地阿拉伯
    • 卡达
    • 南非

第11章 市场力学

  • 促进促进因素
  • 课题

第12章 市场趋势

第13章 价格分析

第14章 专利/ FDA的认证相关分析

  • 新产品开发(核准申请状况)
  • 各企业
  • 登记日
  • 专利到期

第15章 竞争情形

  • 主要企业的简介
    • Zoetis Inc
    • Merck Animal Health
    • Vetoquinol SA
    • Zoetis Inc
    • Virbac SA
    • Boehringer Ingelheim International GmbH
    • Eli Lilly & Co
    • Perrigo Co PLC
    • Sanofi SA
    • Bayer AG
    • Elanco Animal Health Inc
    • Ceva Sante Animale S.A.
    • Covetrus Inc.
    • Idexx Laboratories Inc.
    • Vetoquinol USA, Inc.
    • Norbrook Laboratories, Ltd.
    • Huvepharma EOOD
    • Adivo GmbH
    • Ceva Sant Animale
    • Phibro Animal Health Corp.

第16章 策略性建议

第17章 免责声明

目录
Product Code: 4543

The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products. Animal pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. The restraining factors for the market can be the government rules regarding animal testing, and the probability of sales of fake medicines across e-commerce platforms.

The global animal pharmaceuticals market is segmented on the basis of product type, product, animal type, registration and region. Based on animal type, the market is segmented into companion and production animals. Companion animals tend to hold a larger share in the market as pet owners are concerned for their pet's health and well-being. As compared to production animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment.

The overall animal pharmaceuticals market is widespread, expanding itself to Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America holds the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, fastest growth is shown by the Asia-Pacific sector due to export of animals to other countries. Export process involves testing of the animals with which farm owners need to comply with therefore, the region is expected to witness highest growth over the next five years.

Major players of the animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD, Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing animal healthcare sector.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global animal pharmaceuticals market.
  • To classify and forecast global animal pharmaceuticals market based on product type, product, animal type, registration and region.
  • To identify drivers and challenges for global animal pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global animal pharmaceuticals market.
  • To conduct pricing analysis for global animal pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in global animal pharmaceuticals market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global animal pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Manufacturers, suppliers of medicines, distributors and other stakeholders
  • Animal healthcare centers, vets
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to animal pharmaceuticals
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global animal pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product Type:

Vaccine

Veterinary

Others

  • Market, By Product:

Ectoparasiticides

  • Ivermectin
  • Cypermethrin
  • Fipronil
  • Coumaphos
  • Others

Endoparasiticides

  • Ivermectin
  • Praziquantel
  • Flubendazol
  • Milbemycin
  • Levamisole
  • Fenbendazole
  • Pyrantel
  • Others

Anti-Inflammatories

  • NSAIDs
  • Corticosteroids
  • Others

Bronchodilators

  • Theophylline
  • Albuterol
  • Others
  • Market, By Animal Type:

Companion Animals

Production Animals

  • Market, By Registration:

Generic

Patented

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • United Kingdom
  • Italy
  • France
  • Germany
  • Spain

North America

  • United States
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global animal pharmaceuticals market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers

5. Global Animal Pharmaceuticals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Vaccine, Veterinary, Others)
    • 5.2.2. By Product
      • 5.2.2.1. Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)
      • 5.2.2.2. Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others)
      • 5.2.2.3. Anti-Inflammatories (NSAIDs, Corticosteroids, Others)
      • 5.2.2.4. Bronchodilators (Theophylline, Albuterol, Others)
    • 5.2.3. By Animal Type (Companion Animals, Production Animals)
    • 5.2.4. By Registration (Generic, Patented)
    • 5.2.5. By Region (Asia-Pacific, Europe, North America, South America, MEA)
    • 5.2.6. By Company (2019)
  • 5.3. Product Market Map

6. Asia-Pacific Animal Pharmaceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Product
    • 6.2.3. By Animal Type
    • 6.2.4. By Country (China; India; Japan; South Korea; Australia)
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Animal Pharmaceuticals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. India Animal Pharmaceuticals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Japan Animal Pharmaceuticals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Animal Type
    • 6.3.4. South Korea Animal Pharmaceuticals Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value & Volume
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By Product
        • 6.3.4.2.3. By Animal Type
    • 6.3.5. Australia Animal Pharmaceuticals Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value & Volume
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By Product
        • 6.3.5.2.3. By Animal Type

7. Europe Animal Pharmaceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Product
    • 7.2.3. By Animal Type
    • 7.2.4. By Country (United Kingdom; Italy; France; Germany; Spain)
  • 7.3. Europe: Country Analysis
    • 7.3.1. United Kingdom Animal Pharmaceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. Italy Animal Pharmaceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. France Animal Pharmaceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Germany Animal Pharmaceuticals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Animal Pharmaceuticals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Animal Type

8. North America Animal Pharmaceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Product
    • 8.2.3. By Animal Type
    • 8.2.4. By Country (United States, Canada, Mexico)
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Animal Pharmaceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. Canada Animal Pharmaceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. Mexico Animal Pharmaceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Animal Type

9. South America Animal Pharmaceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Product
    • 9.2.3. By Animal Type
    • 9.2.4. By Country (Brazil, Argentina, Colombia)
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Animal Pharmaceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. Argentina Animal Pharmaceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. Colombia Animal Pharmaceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Animal Type

10. Middle East and Africa (MEA) Animal Pharmaceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Product
    • 10.2.3. By Animal Type
    • 10.2.4. By Country (UAE; Saudi Arabia; Qatar, South Africa)
  • 10.3. Middle East and Africa (MEA): Country Analysis
    • 10.3.1. UAE Animal Pharmaceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. Qatar Animal Pharmaceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Animal Type
    • 10.3.4. South Africa Animal Pharmaceuticals Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Pricing Analysis

14. Patent / FDA Approval Analysis

  • 14.1. New Product Development (NADA, ANADA, CNADA)
  • 14.2. By Company
  • 14.3. Registration Date
  • 14.4. Patent Expiry

15. Competitive Landscape

  • 15.1. Company Profiles (Leading Companies)
    • 15.1.1. Zoetis Inc
    • 15.1.2. Merck Animal Health
    • 15.1.3. Vetoquinol SA
    • 15.1.4. Zoetis Inc
    • 15.1.5. Virbac SA
    • 15.1.6. Boehringer Ingelheim International GmbH
    • 15.1.7. Eli Lilly & Co
    • 15.1.8. Perrigo Co PLC
    • 15.1.9. Sanofi SA
    • 15.1.10. Bayer AG
    • 15.1.11. Elanco Animal Health Inc
    • 15.1.12. Ceva Sante Animale S.A.
    • 15.1.13. Covetrus Inc.
    • 15.1.14. Idexx Laboratories Inc.
    • 15.1.15. Vetoquinol USA, Inc.
    • 15.1.16. Norbrook Laboratories, Ltd.
    • 15.1.17. Huvepharma EOOD
    • 15.1.18. Adivo GmbH
    • 15.1.19. Ceva Sant Animale
    • 15.1.20. Phibro Animal Health Corp.

16. Strategic Recommendations

17. About Us & Disclaimer